University of Washington — Seattle, Washington

Public research footprint of University of Washington, compiled from the ClinicalTrials.gov public registry.

3,543

Registered studies

883

Active

463

Recruiting now

2,029

Completed

500

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 · Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05687110 — Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With… (Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Washington?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.